Safety of Alternative Benznidazole and Nifurtimox Regimens for Adults with Chronic Trypanosoma Cruzi Infection (TESEO): An Open-Label, Randomised, Non-Inferiority Phase 2 Trial

Date

Authors

Cristina Alonso-Vega

Jimy José Pinto

Alejandro Palacios

Virginia Gonzalez

Mónica Laserna

Isabela Ribeiro

E. Ruíz-Villamor

Publisher

RELX Group (Netherlands)

Keywords

Benznidazole, Nifurtimox, Tolerability, Medicine, Discontinuation, Internal medicine, Regimen, Adverse effect, Chagas disease, Trypanosoma cruzi

DOI

10.2139/ssrn.6311846

URI

https://doi.org/10.2139/ssrn.6311846
https://andeanlibrary.org/handle/123456789/84630

Collections

Artículo Científico (Preprint)